Science
A recent news brief service recently sent out highlights about a new study published in NEJM that questions the value of mammography for breast cancer screening while critics cited in the news brief call the study "deeply flawed" and suggest...
Every once in a while there is a headline I just shake my head at, thinking, "how did this research get funded?" This is certainly not the most startling example of this but nonetheless I think most physicians already know this could reject a...
Young Survival Coalition Expresses Concern About Overlooked Moonsho...
I haven't written much about the President's Cancer Moonshot initiative recently and as much as I would like - perhaps because following some Blue Ribbon Panel recommendations and a large number of organizations and individuals expressing, in...
Indica Labs Advance Immuno-oncology Capabilities with Innovative Qu...
Corrales, NM – Indica Labs, a leading provider of software for quantitative evaluation of digital pathology images, is pleased to announce the release of a new module for multiplex chromogenic IHC analysis using HALO™. The Multiplex IHC...
Case Study using HALO™ and STRATA™: Biomarkers of Anti-Tumor Immune...
- Anatomic Pathology
- Clinical Laboratories
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- File format
- General Healthcare News
- Histology
- Image Analysis
- Informatics
- International
- Laboratory Compliance
- Laboratory Informatics
- Laboratory Management & Operations
- Marketing
- Medical Research
- Pathology News
- Science
- Vendor products
- Web/Tech
- Webinars
- Whole slide
Wednesday September 28th | 8 AM PDT | 11 AM EDT | 4 PM BST Presenters Dr. Tricia Cottrell, Johns Hopkins Medical School Vlado Ovtcharov, Indica Labs PD-L1 expression in the tumor microenvironment can be both prognostic and predictive. ...
Potential new technology here that may limit number of breast biopsies previously deemed "unnecessary" using artificial intelligence to aid screening with mammography with tumor protein expression. Perhaps as many as 20% of breast biopsies...
































